Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01118312 · ClinicalTrials.gov registry record · Phase 4
Study of Asthma and Nasal Steroids
A Phase 4 study, sponsored by JHSPH Center for Clinical Trials.
- Completed
- Registry status
- Phase 4
- Development phase
- 388
- Enrollment target
NCT01118312 is a Phase 4 study that has completed, run by JHSPH Center for Clinical Trials. The registered enrollment target is 388 participants.
The verdict
NCT01118312, a Phase 4 study, has completed, sponsored by JHSPH Center for Clinical Trials.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 388 participants
- Enrollment target
Study Summary
The trial will study the effectiveness of nasal steroids for the treatment of chronic rhinitis and/or sinusitis on asthma control.
Interventions
- OTHER Placebo
- DRUG Mometasone Furoate monohydrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 388 participants |
| Start Date | 2010-09 |
| Est. Completion | 2015-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01118312
The ClinicalTrials.gov registry entry for NCT01118312 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 388 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is JHSPH Center for Clinical Trials, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01118312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01118312 about?
NCT01118312 is a clinical study titled "Study of Asthma and Nasal Steroids". The trial will study the effectiveness of nasal steroids for the treatment of chronic rhinitis and/or sinusitis on asthma control.
What is the current status of trial NCT01118312?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 388 participants. The study started on 2010-09. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01118312?
The interventions under investigation include: Placebo (OTHER), Mometasone Furoate monohydrate (DRUG).
Who is sponsoring clinical trial NCT01118312?
This trial is sponsored by JHSPH Center for Clinical Trials, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.